12 Health Care Stocks Moving In Friday's Pre-Market Session
BioRestorative Therapies Inc BRTX
$0.20
▼ -9.22%
($-0.02)
⬇️ Below Yest. Low
🗓️ Earnings Next Week
Open
$0.23
Prev Close
$0.23
Day Range
$0.19 – $0.24
52W Range
$0.16 – $1.89
Market Cap
$5.22M
Beta
0.74
EPS (TTM)
$-1.09
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2001-07-11 |
| Shares Out. | 25,480,000 |
| Website | biorestorative.com/ ↗ |
| Phone | 16317608100 |
| Employees | 14 |
| Revenue | $23,170 |
| Gross Profit | $15,785 |
| Net Income | -$2.2M |
| Free Cash Flow | -$11.9M |
| Total Assets | $4.6M |
| Total Liabilities | $1.6M |
| Equity | $3.0M |
About BioRestorative Therapies Inc
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
BioRestorative Therapies Inc is a publicly traded company under the ticker symbol BRTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-07-01)